Marshall Wace
NUTX

Marshall Wace’s Nutex Health NUTX Stock Holding History

Marshall Wace’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-94,548
Closed -$11.8M – 3240
2025
Q2 		$11.8M Buy
94,548
+72,734
+333% +$9.4M 0.01% 787
2025
Q1 		$1.03M Sell
21,814
-17,397
-44% -$849K ﹤0.01% 1771
2024
Q4 		$1.24M Sell
39,211
-30,345
-44% -$865K ﹤0.01% 1631
2024
Q3 		$1.51M Buy
+69,556
New +$1M ﹤0.01% 1481

Other funds holding NUTX

TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Marshall Wace's NUTX Position: Q3 2025 in Review

Marshall Wace sold out of Nutex Health (NUTX) in Q3 2025, closing a stake of 94,548 shares — an estimated $11.8M sold.

Marshall Wace first reported a position in NUTX in Q3 2024 and held it in 4 quarters. The position peaked at $11.8M in Q2 2025. 95 funds tracked by Wall St. Rank hold NUTX as of Q3 2025.

  • Marshall Wace reported no remaining Nutex Health position as of Q3 2025 after selling out during the quarter.
  • Marshall Wace sold 94,548 Nutex Health shares in Q3 2025, an estimated $11.8M.
  • Marshall Wace first reported a position in Nutex Health in Q3 2024 and held it in 4 quarters.
  • Marshall Wace's Nutex Health position peaked at $11.8M in Q2 2025.
  • 95 funds tracked by Wall St. Rank held Nutex Health as of Q3 2025.

Based on Marshall Wace's 13F filing for Q3 2025, filed 13 Nov 2025.